Many Ways Pharmaceutical Consultants Can Shape Business And Marketing Outcomes

While straightforward economics may dictate that a pharmaceutical company's bottom line is really driven by the need to sell its products for monetary gain, a more holistic view should be taken. The company occupies a key position, from a marketing perspective, between the government and other regulators and ultimately the patient. There is a complex understanding and relationship between all the main players and pharmaceutical consultants help to emphasise these individual roles, as they disseminate information to help oil all the moving parts of this complex machine.

Pharmaceutical companies must conform to strict FDA regulations, best use practices and study scientific benchmarks to provide products and services for ongoing use. The importance of marketing in this environment should never be underestimated. As the advisor to the consumer, a pharmacist or physician has a lot of input and must satisfy the patient, whilst also adhering to budgetary restrictions, insurance company stipulations and positions.

The direct communication between health care professionals and the pharmaceutical companies through various marketing channels ultimately dictates the efficient delivery of products and services to the end-user, the patient. There is a lot at stake as the patient's ability to lead a healthy and productive life can be affected by the quality and standard of the marketing trail. Marketing in this environment is most certainly a two-way operation. In addition to the company's communication with the professional about the benefits and risks associated, the science behind the introduction of the products and ways for dissemination and consumption, the professional also communicates back to the company with feedback, real-time findings and data.

The contribution of pharma consulting should never be underestimated as it can help to emphasise how certain conditions can be treated by emerging products and help to reveal how other illnesses, previously under-served, could be addressed. We still have many conditions without a cure and pharmaceutical company research can often go a long way to bridging that gap, if not even enabling cutting-edge treatment for patients. Just because the pharmaceutical products may exist, it does not mean that these products will find their way into the hands of the consumer. Marketing plays a critical role in disseminating the information from one end of the chain to the other, into the hands of the professionals for communication with the patient.

As more and more information is revealed through scientific study, product creation and government rubber-stamping, more of a spotlight is turned on the need for treatment of chronic diseases. For example, certain side effects or by-products of a critical element may not have been apparent, or the link between illness and cure revealed, unless and until adequate marketing channels are open between the researchers, producers, professionals and patients.

Generally, pharmaceutical consulting firms are highly skilled at developing communication between vital parties and educating all players. Their experience, knowledge and enthusiasm can really help to turn the wheels of the marketing machine, continuously engaging all key players and producing incredible results in such a competitive environment.

Alan Gillies is the Director of L2L Consulting, an elite pharmaceutical consultancy firm which specialises in Strategy Development and Implementation Excellence for prestigious multi-national organisations.